Global Breast Biopsy Market - Mammography Guided Stereotactic Biopsy Holds the Largest Share


Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Breast Biopsy Market (Core Needle, Vacuum Assisted & Fine Needle Aspiration): Insights & Forecast (2023-2027)" report has been added to ResearchAndMarkets.com's offering.

The global breast biopsy market is projected to reach US$1.90 billion in 2027, experiencing a growth rate of 8.72% during the period spanning from 2023 to 2027.

The market growth is driven by factors such as the increasing prevalence of breast cancer and the rising female population aged 65 or above. Additionally, the growing adoption of liquid biopsy is expected to have a positive impact on the breast biopsy market.

Key highlights from the report:

  • Types of Breast Biopsies: The global breast biopsy market is segmented by type, including core needle biopsy (CNB), vacuum-assisted biopsy (VAB), and fine needle aspiration biopsy (FNAB). In 2022, core needle biopsy (CNB) held the dominant share of the market, followed by vacuum-assisted biopsy (VAB).
  • Image Guided Technology: The market is further segmented based on image-guided technology, which includes mammography guided stereotactic biopsy, ultrasound-guided biopsy, MRI-guided biopsy, and CT-guided biopsy. In 2022, the largest share of the market was held by mammography guided stereotactic biopsy.
  • Regional Analysis: The report analyzes the market dynamics and trends in the North America, Europe, Asia Pacific, and Rest of the World (ROW) regions. In 2022, North America held the dominant share of the market, followed by Europe and Asia Pacific.

Company Profiles:

The report provides detailed profiles of leading players in the global breast biopsy market, including:

  • Hologic
  • Danaher Corporation
  • Becton, Dickinson & Company
  • Roche Group
  • Medtronic
  • Qiagen

Overall, the report offers valuable insights and forecasts to help stakeholders understand the current market landscape and plan effective strategies for growth in the global breast biopsy market.

Key Attributes:

Report AttributeDetails
No. of Pages71
Forecast Period2023 - 2027
Estimated Market Value (USD) in 2023$1.36 Billion
Forecasted Market Value (USD) by 2027$1.9 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal


For more information about this report visit https://www.researchandmarkets.com/r/fw23mp

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Global Breast Biopsy Market

Contact Data